Quantification of undetectable plasma HIV RNA

by N. Margot, D. Koontz, S. Mccallister, J. Mellors, C. Callebaut
Published 2017-12-01

Co-expression of multiple inhibitory receptors on CD8+ T cells in viremic and ART-suppressed HIV-1(+) individuals

by B. Macatangay, C. Klamar Blain, F. Hong, J. Bui, A. Cillo, J. Mellors
Published 2015-12-01

Updates on two public databases for studies of HIV persistence; the Retrovirus Integration Database (RID) and HIV Proviral Sequence Database (PSD)

by W. Shao, J. Shan, W.S. Hu, E. Halvas, J. Mellors, J. Coffin, M. Kearney
Published 2019-12-01

High-throughput sequencing of integrated HIV-1 reveals novel proviral structures

by K. Joseph, E. Halvas, L. Brandt, S. Patro, J. Rausch, M. Kearney, J. Coffin, J. Mellors
Published 2019-12-01

Automated high-throughput quantification of persistent HIV-1 plasma viremia in individuals on ART

by J. Jacobs, M. Tosiano, D. Koontz, A. Worlock, K. Harrington, K. Shutt, S. Bakkour, M. Busch, J. Mellors
Published 2019-12-01

Cellular HIV RNA/DNA as biomarkers of inducible virion production

by A. Cillo, F. Hong, A. Tsai, A. Irrinki, J. Kaur, J. Lalezari, D. Sloan, J.P. Murry, J. Mellors
Published 2015-12-01

Proviral landscape in children parallels adults and enables reservoir reconstruction

by J. Hasson, M.G. Katusiime, S. Smith, M. Cotton, E. Boritz, J. Coffin, J. Mellors, S. Patro, G. Van Zyl, M. Kearney
Published 2019-12-01

Th2 cytokines are associated with higher levels of intact proviruses on ART

by J. Cyktor, H. Mar, G. Laird, R. Bosch, A. Martin, J. Eron, B. Macatangay, D. Mcmahon, R. Gandhi, J. Mellors
Published 2019-12-01

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy

by J. Cyktor, R. Gandhi, R. Bosch, H. Mar, G. Laird, B. Macatangay, J. Eron, R. Siliciano, D. Mcmahon, J. Mellors
Published 2019-12-01

Long-term persistence of HIV-infected cell clones in early treated children

by M. Bale, M.G. Katusiime, D. Wells, X. Wu, J. Coffin, M. Cotton, S. Hughes, J. Mellors, G. Van Zyl, M. Kearney
Published 2019-12-01

Persistence of CD4+PD-1 high T cells despite long-term suppressive ART

by B. Macatangay, R. Gandhi, D. Mcmahon, C. Lalama, R. Bosch, J. Cyktor, C. Hensel, E. Hogg, J. Eron, J. Mellors, C. Rinaldo
Published 2017-12-01

Next generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 reservoir size

by M. Stone, D. Rosenbloom, P. Bacchetti, X. Deng, M. Busch, M. Dimapasoc, S. Keating, D. Richman, J. Mellors, S. Deeks, J. Siliciano, N. Chomont, R. Ptak
Published 2017-12-01

Blinded evaluation of ultrasensitive assays of HIV in plasma

by S.M. Keating, M. Stone, X. Deng, J. Mellors, S. Bakkour, D. Richman, R. Gorelick, J. Lifson, C. Jennings, M. Stengelin, G. Wu, B.J. Howell, P. Bacchetti, M.P. Busch
Published 2017-12-01

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic

by T. R. W. Tipton, Y. Hall, J. A. Bore, A. White, L. S. Sibley, C. Sarfas, Y. Yuki, M. Martin, S. Longet, J. Mellors, K. Ewer, S. Günther, M. Carrington, M. K. Kondé, M. W. Carroll
Published 2021-02-01

Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals

by S. Riddler, M. Para, C. Benson, A. Mills, M. Ramgopal, E. Dejesus, C. Brinson, J. Cyktor, J. Mellors, S. Guo, B. Doehle, S. Markova, H. Patel, H. Graham, J. Hesselgesser, R. Geleziunas, D. Brainard, S. McCallister, D. Sengupta
Published 2019-07-01

Different regimens of romidepsin administration for reversion of SIV latency in a rhesus macaque model of complete virus control

by A. Kleinman, S. Murali Kilapandal Venkatraman, E. Penn, B. Policicchio, P. Sette, E. Brocca-Cofano, M. Cottrell, R. Sivanandham, A. Valentine, C. Xu, K. Raehtz, T. Dunsmore, G. Haret-Richter, A. Kashuba, J. Mellors, I. Pandrea, C. Apetrei
Published 2019-07-01